204 related articles for article (PubMed ID: 19187806)
1. Radioimmunotherapy of infectious diseases.
Dadachova E; Casadevall A
Semin Nucl Med; 2009 Mar; 39(2):146-53. PubMed ID: 19187806
[TBL] [Abstract][Full Text] [Related]
2. Cryptococcus neoformans as a Model for Radioimmunotherapy of Infections.
Dadachova E; Casadevall A
Interdiscip Perspect Infect Dis; 2011; 2011():830286. PubMed ID: 21747848
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.
Dadachova E; Howell RW; Bryan RA; Frenkel A; Nosanchuk JD; Casadevall A
J Nucl Med; 2004 Feb; 45(2):313-20. PubMed ID: 14960655
[TBL] [Abstract][Full Text] [Related]
4. Treatment of infection with radiolabeled antibodies.
Dadachova E; Casadevall A
Q J Nucl Med Mol Imaging; 2006 Sep; 50(3):193-204. PubMed ID: 16868533
[TBL] [Abstract][Full Text] [Related]
5. Radiolabeled Antibodies for Therapy of Infectious Diseases.
Dadachova E; Casadevall A
Microbiol Spectr; 2014 Dec; 2(6):. PubMed ID: 26104440
[TBL] [Abstract][Full Text] [Related]
6. Toward developing a universal treatment for fungal disease using radioimmunotherapy targeting common fungal antigens.
Bryan RA; Guimaraes AJ; Hopcraft S; Jiang Z; Bonilla K; Morgenstern A; Bruchertseifer F; Del Poeta M; Torosantucci A; Cassone A; Nosanchuk JD; Casadevall A; Dadachova E
Mycopathologia; 2012 Jun; 173(5-6):463-71. PubMed ID: 22048869
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunotherapy of infection with Bi-labeled antibodies.
Dadachova E
Curr Radiopharm; 2008 Sep; 1(3):234-239. PubMed ID: 20228957
[TBL] [Abstract][Full Text] [Related]
8. Antibodies as delivery vehicles for radioimmunotherapy of infectious diseases.
Dadachova E; Casadevall A
Expert Opin Drug Deliv; 2005 Nov; 2(6):1075-84. PubMed ID: 16296810
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy for the treatment of infectious diseases: a comprehensive update.
Carvalho JLC; Dadachova E
Expert Rev Anti Infect Ther; 2023 Apr; 21(4):365-374. PubMed ID: 36815406
[TBL] [Abstract][Full Text] [Related]
10. Radiolabeled antibodies for therapy of infectious diseases.
Dadachova E; Casadevall A
Microbiol Spectr; 2014 Nov; 2(6):0023. PubMed ID: 25599011
[TBL] [Abstract][Full Text] [Related]
11. Preclinical testing of radiopharmaceuticals for novel applications in HIV, bacterial and fungal infectious diseases.
Shah M; Garg G; Dadachova E
Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):317-26. PubMed ID: 26200222
[TBL] [Abstract][Full Text] [Related]
12. Interaction of radiolabeled antibodies with fungal cells and components of the immune system in vitro and during radioimmunotherapy for experimental fungal infection.
Dadachova E; Bryan RA; Apostolidis C; Morgenstern A; Zhang T; Moadel T; Torres M; Huang X; Revskaya E; Casadevall A
J Infect Dis; 2006 May; 193(10):1427-36. PubMed ID: 16619191
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy of fungal diseases: the therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens.
Nosanchuk JD; Dadachova E
Front Microbiol; 2011; 2():283. PubMed ID: 22275913
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
[TBL] [Abstract][Full Text] [Related]
15. Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer.
Deshayes E; Ladjohounlou R; Le Fur P; Pichard A; Lozza C; Boudousq V; Sevestre S; Jarlier M; Kashani R; Koch J; Sosabowski J; Foster J; Chouin N; Bruchertseifer F; Morgenstern A; Kotzki PO; Navarro-Teulon I; Pouget JP
J Nucl Med; 2018 Aug; 59(8):1234-1242. PubMed ID: 29674421
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunotherapy as a Novel Approach in HIV, Bacterial, and Fungal Infectious Diseases.
Helal M; Dadachova E
Cancer Biother Radiopharm; 2018 Oct; 33(8):330-335. PubMed ID: 30133305
[TBL] [Abstract][Full Text] [Related]
17. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
Aghevlian S; Boyle AJ; Reilly RM
Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
[TBL] [Abstract][Full Text] [Related]
19. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
[TBL] [Abstract][Full Text] [Related]
20. Overview of studies on experimental radioimmunotherapy.
Knox SJ
Cancer Res; 1995 Dec; 55(23 Suppl):5832s-5836s. PubMed ID: 7493355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
